Home > Clinical Trials

Saved trials

NOT_YET_RECRUITING
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapy
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Prostate Cancer Metastatic


Prostate Cancer


CRPC
COMPLETED
NCT03248492
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
253 Enrollment(s)
99 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
NOT_YET_RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
RECRUITING
NCT06525298
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
144 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Tumor


Homologous Recombination Deficiency


HRR Deficiency
ACTIVE_NOT_RECRUITING
NCT05804747
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
1,204 Enrollment(s)
33 Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation
RECRUITING
NCT05744375
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
41 Enrollment(s)
19 Study location(s)
INTERVENTIONAL (PHASE2)
Locally Advanced Breast Cancer


Metastatic Breast Cancer
COMPLETED
NCT05419583
Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction
60 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (NA)
Myocardial Infarction Type 2
TERMINATED
NCT03735875
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia
8 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia With FLT3/ITD Mutation


Recurrent Acute Myeloid Leukemia


Refractory Acute Leukemia